IDEAYA Biosciences, Inc. (IDYA) Covered Calls

You can sell covered calls on IDEAYA Biosciences, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for IDYA (prices last updated Wed 4:16 PM ET):

IDEAYA Biosciences, Inc. (IDYA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
41.18 +0.53 39.29 42.65 1.1M - 2.6
Covered Calls For IDEAYA Biosciences, Inc. (IDYA)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
May 17 40 2.55 40.10 -0.2% -4.3%
Jun 21 40 4.10 38.55 3.8% 26.7%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

IDEAYA Biosciences, Inc., an oncology-focused precision medicine company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's product candidate is IDE196, a protein kinase C inhibitor that is in Phase 1/2 clinical trial for genetically-defined cancers having GNAQ or GNA11 gene mutations. Its preclinical pipeline includes various synthetic lethality programs targeting MAT2A for solid tumors with MTAP deletions; Pol-theta in tumors with homologous recombination deficiency, including BRCA mutations; PARG in tumors with BRCA2 mutations in base excision repair; and WRN in high microsatellite instability tumors. The company has a research collaboration agreement with Cancer Research UK and the University of Manchester to develop small molecule inhibitors of Poly (ADP-ribose) glycohydrolase; and a clinical trial collaboration and supply agreement with Pfizer Inc. for Phase 1/2 study in metastatic uveal melanoma and other solid tumors, as well as a strategic partnership with GlaxoSmithKline plc. IDEAYA Biosciences, Inc. was founded in 2015 and is headquartered in South San Francisco, California.